MarketCap
Facebook
X
TelegramQuarterly report 2026-Q2
added 06-05-2026
The Cooper Companies Operating Cash Flow 2011-2026 | COO
Annual Operating Cash Flow The Cooper Companies
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 796 M | 709 M | 608 M | 692 M | 739 M | 487 M | 713 M | 669 M | 594 M | 510 M | 391 M | 455 M | 416 M | 315 M | 336 M | 268 M | 223 M | 96.5 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 796 M | 96.5 M | 501 M |
Quarterly Operating Cash Flow The Cooper Companies
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 444 M | 261 M | 261 M | - | - | - | 191 M | - | - | - | 123 M | - | - | - | 167 M | 562 M | - | - | 148 M | 564 M | 340 M | - | 130 M | 268 M | 156 M | - | 102 M | 513 M | 317 M | - | 26.2 M | 432 M | 197 M | - | 108 M | 395 M | - | - | 89.5 M | 316 M | 187 M | - | 79.8 M | 286 M | 190 M | - | 68.6 M | 303 M | 195 M | - | 47.6 M | 266 M | 163 M | - | 41.6 M | 200 M | 122 M | - | 72.9 M | 225 M | 138 M | - | 203 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 564 M | 26.2 M | 222 M |
Operating Cash Flow of other stocks in the Medical instruments industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
20 K | - | - | $ 810 M |  USA |
 |
Glaukos Corporation
GKOS
|
-14.8 M | $ 126.34 | 3.59 % | $ 7.23 B | USA |
 |
Intuitive Surgical
ISRG
|
3.03 B | $ 426.61 | 1.91 % | $ 152 B | USA |
 |
Alcon
ALC
|
1.34 B | $ 67.9 | 2.71 % | $ 40.4 B |  Schweiz |
 |
ICU Medical
ICUI
|
180 M | $ 142.0 | 3.29 % | $ 3.5 B | USA |
 |
iRhythm Technologies
IRTC
|
80.9 M | $ 113.83 | 6.15 % | $ 3.64 B | USA |
 |
Repro Med Systems
KRMD
|
462 K | $ 4.0 | 0.25 % | $ 185 M | USA |
 |
LeMaitre Vascular
LMAT
|
81.3 M | $ 96.59 | 1.56 % | $ 2.19 B | USA |
 |
Masimo Corporation
MASI
|
196 M | $ 179.95 | 0.01 % | $ 9.59 B | USA |
 |
Microbot Medical
MBOT
|
-13 M | $ 1.82 | - | $ 83.3 M |  Israel |
 |
Ekso Bionics Holdings
EKSO
|
-11.8 M | - | - | $ 28.6 M | USA |
 |
Milestone Scientific
MLSS
|
-2.92 M | $ 0.39 | 0.29 % | $ 32 M | USA |
 |
Merit Medical Systems
MMSI
|
297 M | $ 67.51 | 2.24 % | $ 3.99 B | USA |
 |
electroCore
ECOR
|
-8.19 M | $ 9.52 | -1.24 % | $ 80.8 K | USA |
 |
Envista Holdings Corporation
NVST
|
276 M | $ 24.59 | 4.91 % | $ 4.13 B | USA |
 |
Haemonetics Corporation
HAE
|
293 M | $ 78.71 | 5.11 % | $ 3.71 B | USA |
 |
STERIS plc
STE
|
1.34 B | $ 212.88 | 1.1 % | $ 20.9 B | USA |
 |
Isoray
ISR
|
-82.5 M | - | 0.03 % | $ 108 M | USA |
 |
STAAR Surgical Company
STAA
|
-34.2 M | $ 29.87 | -0.3 % | $ 1.48 B | USA |
 |
InfuSystem Holdings
INFU
|
24.4 M | $ 9.01 | - | $ 186 M | USA |
 |
Utah Medical Products
UTMD
|
14.7 M | $ 68.07 | 1.52 % | $ 221 M | USA |
 |
West Pharmaceutical Services
WST
|
755 M | $ 334.66 | 4.66 % | $ 24.2 B | USA |
 |
Pulse Biosciences
PLSE
|
-54.1 M | $ 25.77 | 3.74 % | $ 1.74 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
235 M | $ 10.47 | 2.05 % | $ 2.09 B | USA |
 |
Retractable Technologies
RVP
|
-7.06 M | $ 0.69 | 0.16 % | $ 20.7 M | USA |
 |
Pro-Dex
PDEX
|
-1.68 M | $ 65.0 | - | $ 214 M | USA |
 |
Predictive Oncology
POAI
|
-13.2 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
20.1 M | $ 27.55 | 5.56 % | $ 1.32 B | USA |
 |
Stereotaxis
STXS
|
-13.7 M | $ 1.85 | 2.21 % | $ 168 M | USA |
 |
Baxter International
BAX
|
845 M | $ 20.03 | 4.16 % | $ 10.3 B | USA |
 |
ResMed
RMD
|
351 M | $ 196.94 | 1.97 % | $ 28.8 B | USA |
 |
AtriCure
ATRC
|
57.3 M | $ 27.3 | 1.43 % | $ 1.3 B | USA |
 |
Harvard Bioscience
HBIO
|
6.73 M | $ 6.04 | 0.5 % | $ 268 M | USA |
 |
NeuroMetrix
NURO
|
-7.13 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
-10.1 M | $ 12.34 | 3.44 % | $ 504 M | USA |
 |
Becton, Dickinson and Company
BDX
|
3.33 B | $ 152.04 | 2.08 % | $ 43.7 B | USA |
 |
Nephros
NEPH
|
1.64 M | $ 3.25 | -4.13 % | $ 34.5 M | USA |
 |
OraSure Technologies
OSUR
|
-49 M | $ 4.24 | 2.17 % | $ 312 M | USA |
 |
Repligen Corporation
RGEN
|
117 M | $ 130.13 | 3.83 % | $ 7.32 M | USA |